CopyMark Law Group
4.9/5
Drawing for ARCHBOW

USPTO serial 87885902

ARCHBOW

Reviewed by CopyMark Law Group

Reg. 5622217Status 702Registered
Filing date
Status date
Registration date
Dec 4, 2018
Examiner
PAQUIN, SAMUEL ROBERT
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with ARCHBOW?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joy J. Wildes

Joy J. Wildes Davis+Gilbert LLP1675 Broadway, 31st FloorNew York, NY 10019United States

Goods and services

ClassDescriptionStatusFirst use
035Business consultancy; Business management consulting and advisory services; Business management consulting, strategic planning and business advisory services provided to the pharmaceutical, biotechnology and manufacturing industries, to drug distribution companies and to patient support providers; International business consulting services relating to global market access, product distribution strategies, risk management strategies, regulatory issues, and patient support services; Consultancy and advisory services in the field of business strategy; Providing business management information in connection with consulting and advisory services in the field of strategic planningACTIVEOct 1, 2017
041On-line journals, namely, blogs featuring news, information and commentary for the pharmaceutical and biotechnology industries; Providing a website featuring blogs and non-downloadable publications in the nature of articles and case studies in the field(s) of pharmaceuticals and biotechnologyACTIVEOct 1, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 22, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 22, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 22, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 2, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Dec 4, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 4, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 18, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 18, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 29, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 14, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 10, 2018DOCKASSIGNED TO EXAMINER—
May 1, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 24, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance